Globalworld globe
United Kingdom
North America
  • facebook
  • linkedin
Medical Developments International
  • Home
  • Products
    • Asthma & COPD
    • Penthrox
    • Medical Devices
    • Veterinary
  • About
    • Distributor Information
    • Careers
    • Associations
  • Investors/Media
    • Financial Reports
    • Board of Directors/Management
    • Corporate Governance
    • Media Centre
    • Diversity Policy
    • Share Trading Policy
  • Healthcare Professionals
  • Contact

News

Penthrox submitted for Regulatory Approval in 22 European Countries

Nov 29, 2016Mark EdwardsNews

29 November 2016

ASX ANNOUNCEMENT

PENTHROX SUBMITTED FOR REGULATORY APPROVAL IN 22 EUROPEAN COUNTRIES

Medical Developments International Limited (ASX:MVP) is delighted to confirm that its partner in Western Europe, Mundipharma International Corporation Limited (Mundipharma) submitted an application on 28 November 2016 to the United Kingdom?s Medicines & Healthcare products Regulatory Agency (MHRA) under the Decentralised Procedure to have Penthrox approved for sale in:

Austria, Denmark, Italy, Poland, Spain, Bulgaria, Estonia, Latvia,?Portugal, Sweden, Croatia, Finland, Lithuania, Romania, Cyprus, Germany, Luxembourg, Slovakia, Czech Republic, Iceland Norway and Slovenia.

For details relating to the full ASX release, please click on the following link:?European-Regulatory-Submission

Contact Us

for information on our range of products

Find a distributor

in our global network

Investors

invest in a company with
innovative foresight

News

  • MVP Completes $25m Placement

    14 December 2020 ASX ANNO...

  • EU Transition and Trading Update

    3 December 2020 ASX ANNOU...

  • MVP Board Re-organisation

    3 December 2020 ASX ANNOU...

Healthcare Professional Registration

Login to access healthcare professional resources



Remember Me


Forgot password? | Register

Medical Developments International

Address:
4 Caribbean Drive, Scoresby,
Victoria, 3179
Australia
Phone: +61 3 9547 1888
Email: mdi@medicaldev.com
ABN: 14 106 340 667
For Medical Enquiries:

Phone: 1800 PENTHROX (1800 736 847)
Email: medinf@medicaldev.com

Email Newsletter

Sign up to our newsletter to receive MDI corporate, investor  & media news.